LOW-DOSE GEMCITABINE IN PROLONGED INFUSION AND CISPLATIN FOR THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

被引:0
|
作者
Kovac, Vilijem [1 ]
Zwitter, Matjaz [1 ]
Rajer, Mirjana [1 ]
机构
[1] Inst Oncol Ljubljana, Dept Radiotherapy, Ljubljana, Slovenia
关键词
Cisplatin; malignant pleural mesothelioma; Chemotherapy; gemcitabine;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1359 / S1360
页数:2
相关论文
共 50 条
  • [1] A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
    Kovac, Viljem
    Zwitter, Matjaz
    Rajer, Mirjana
    Marin, Aleksander
    Debeljak, Andrej
    Smrdel, Uros
    Vrankar, Martina
    ANTI-CANCER DRUGS, 2012, 23 (02) : 230 - 238
  • [2] Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I-IItrial
    Kovac, V
    Zwitter, M
    Smrdel, U
    Debeljak, A
    Cesar, R
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 131 - 134
  • [3] Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I and II trials
    Kovac, V
    Zwitter, M
    Smrdel, U
    Debeljak, A
    Cesar, R
    Izidor, K
    LUNG CANCER, 2004, 45 : S68 - S68
  • [4] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
    Oscar Arrieta
    Diego López-Macías
    Víctor-Osvaldo Mendoza-García
    Ludwing Bacon-Fonseca
    Wendy Muñoz-Montaño
    Eleazar-Omar Macedo-Pérez
    Saé Muñiz-Hernández
    Monika Blake-Cerda
    José-Francisco Corona-Cruz
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 975 - 982
  • [5] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
    Arrieta, Oscar
    Lopez-Macias, Diego
    Mendoza-Garcia, Victor-Osvaldo
    Bacon-Fonseca, Ludwing
    Munoz-Montano, Wendy
    Macedo-Perez, Eleazar-Omar
    Muniz-Hernandez, Sae
    Blake-Cerda, Monika
    Corona-Cruz, Jose-Francisco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 975 - 982
  • [6] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
    Rodriguez, Oscar
    Lopez, Diego
    Osvaldo Mendoza-Garcia, Victor
    Bacon Fonseca, Ludwing Alexander
    Munoz-Montano, Wendy
    Macedo, Omar
    Muniz-Hernandez, Sae
    Blake, Monika
    Corona, Jose F.
    De La Garza, Jaime G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
    Arrieta, Oscar
    Munoz-Montano, Wendy
    Muniz-Hernandez, Sae
    Campos, Saul
    Catalan, Rodrigo
    Soto-Molina, Herman
    Guzman Vazquez, Silvia
    Diaz-Alvarez, Osvaldo
    Martinez-Pacheco, Victor
    Turcott, Jenny G.
    Ramos-Ramirez, Maritza
    Cabrera-Miranda, Luis
    Barron, Feliciano
    Cardona, Andres F.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] SUCCESSFUL TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA WITH CISPLATIN AND GEMCITABINE IN A HEMODIALYSIS PATIENT
    Saida, Y.
    Watanabe, S.
    Sato, K.
    Okajima, M.
    Miura, S.
    Tanaka, J.
    Kagamu, H.
    Yoshizawa, H.
    Narita, I.
    ANNALS OF ONCOLOGY, 2013, 24
  • [9] Prolonged low-dose infusion for gemcitabine: a systematic review
    Zhao, Dehua
    Chen, Jing
    Chu, Mingming
    Wang, Jisheng
    ONCOTARGETS AND THERAPY, 2019, 12 : 4859 - 4868
  • [10] RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
    Wendy Muñoz-Montaño
    Sae Muñiz-Hernández
    Alejandro Avilés-Salas
    Rodrigo Catalán
    Luis Lara-Mejía
    Suraj Samtani-Bassarmal
    Andres F. Cardona
    Jorge Mendoza-Desión
    Daniel Hernández-Cueto
    Altagracia Maldonado
    Guillermina Baay-Guzmán
    Sara Huerta-Yepes
    Oscar Arrieta
    BMC Cancer, 21